Jeffrey J Siracuse
Overview
Explore the profile of Jeffrey J Siracuse including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
274
Citations
1297
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Auda M, Ratner M, Chang H, Johnson W, Siracuse J, Shariff S, et al.
Ann Vasc Surg
. 2025 Mar;
PMID: 40054603
Objectives: While the use of endovascular intervention for peripheral artery disease (PAD) has expanded in recent years, there remains relatively few studies focused on the endovascular treatment of isolated popliteal...
2.
Powell R, Farber A, Doros G, Chew D, Conte M, Dake M, et al.
J Vasc Interv Radiol
. 2025 Feb;
PMID: 40015448
Purpose: To analyze the causes and clinical impacts of endovascular technical failure (ETF) in the BEST-CLI trial, which compared endovascular therapy to bypass surgery in patients with chronic limb-threatening ischemia...
3.
Alonso A, Kobzeva-Herzog A, Levin S, de Macedo K, Melvin J, Farber A, et al.
J Vasc Surg
. 2025 Feb;
PMID: 39923916
Objective: Perioperative stroke after carotid artery stenting (CAS) is rare. However, the degree of disability and long-term effects from a postoperative stroke remain unclear. Our goal was to assess the...
4.
Alonso A, Kobzeva-Herzog A, Dalton-Petillo S, Haqqani M, Farber A, King E, et al.
J Vasc Surg
. 2025 Jan;
PMID: 39880293
Objective: In April 2022, the Society for Vascular Surgery (SVS) published the Appropriate Use Criteria (AUC) for the management of intermittent claudication (IC). Our goal was to compare practice patterns...
5.
Sung E, Awtry E, Koh D, McNamara T, Kang H, Farber A, et al.
J Vasc Surg
. 2025 Jan;
PMID: 39800124
Objective: Infective endocarditis (IE) is associated with significant morbidity and mortality and places patients at risk for subsequent peripheral vascular emboli. Our goals were to analyze the incidence of peripheral...
6.
Dalton-Petillo S, Siracuse J
Semin Vasc Surg
. 2024 Dec;
37(4):394-399.
PMID: 39675847
Hemodialysis (HD) access for patients with end-stage renal disease is a steadily increasing necessity, and maintaining patency of native or synthetic fistulas can be challenging. The main physiologic changes of...
7.
Siracuse J, Farber A, Menard M, Rosenfield K, Conte M, Schanzer A, et al.
J Vasc Surg
. 2024 Dec;
81(3):720-729.e1.
PMID: 39638100
Objective: Wound, Ischemia, and foot Infection (WIfI) staging was established to provide objective classification in patients with chronic limb-threatening ischemia (CLTI) and to predict 1-year major amputation risk. Our goal...
8.
Straus S, Farah M, Pillai K, Siracuse J, Siracuse J, Alsaigh T, et al.
J Vasc Surg
. 2024 Dec;
81(3):606-612.
PMID: 39617079
Objective: Hypertension (HTN) has been well-documented as a strong predictive factor for worse outcomes in patients undergoing various cardiovascular procedures. However, limited research has investigated the effect of controlled vs...
9.
Ratner M, Chang H, Rockman C, Pearce B, Siracuse J, Cho J, et al.
Eur J Vasc Endovasc Surg
. 2024 Oct;
69(1):81-87.
PMID: 39395529
Objective: Patients with polyvascular disease are considered high risk for major adverse cardiac events (MACE). This retrospective study used the Vascular Quality Initiative (VQI) database to quantify the effect of...
10.
McDermott K, White M, Bose S, Tan L, Columbo J, Siracuse J, et al.
Ann Vasc Surg
. 2024 Oct;
113:370-381.
PMID: 39362465
Background: Differential access to new technologies may contribute to racial disparities in surgical outcomes but has not been well-studied in the treatment of carotid artery stenosis. We examined race-based differences...